Knowledge hub.
Stay up-to-date with the latest industry news, trends, insights and research. This section provides valuable information and resources.
or
Blogs, Rare diseases
Strategic timing: When should biotech firms consider launching expanded access programs?
Blogs, Rare diseases
How to set up an EAP without a European presence
Blogs, Rare diseases
EMA orphan drug designation
Blogs, Rare diseases
Four considerations before collecting real-world data in your EAP
Blogs, Rare diseases
The increasing importance of real-world data for the EMA
Blogs, Rare diseases
Six steps for a successful Expanded Access Program in Europe
Thought Leadership, Rare diseases
Navigating the transition from open label extensions to early access programs
News
Sciensus achieves ISO certification for best practices in the processing of personal data
News
Sciensus names Christian Tucat as Chief Executive Officer